MedTrace Logo

Post-approval Study of the DURALOC® Option Ceramic-on-Ceramic Hip Prosthesis System

NCT00546598 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 106

Last updated 2021-11-30

No results posted yet for this study

Summary

This study is being conducted to gather medium and long-term information regarding the performance and safety of the commercially available DURALOC® Option Ceramic-on-Ceramic Hip Prosthesis System.

Conditions

  • Non-inflammatory Joint Disease
  • Osteoarthritis
  • Avascular Necrosis
  • Congenital Hip Dysplasia
  • Post-traumatic Arthritis

Interventions

DEVICE

Total hip replacement/arthroplasty

Hip replacement

Sponsors & Collaborators

  • DePuy Orthopaedics

    lead INDUSTRY

Principal Investigators

  • Dave Whalen, BS, DC · DePuy Orthopaedics

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-01-01
Primary Completion
2014-04-01
Completion
2014-04-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00546598 on ClinicalTrials.gov